Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00198029 · ClinicalTrials.gov registry record · NA

An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study

A NA study, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT00198029: Completed NA study, sponsored by Hospital for Special Surgery, New York.

NCT00198029 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00198029, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of this study is to find out if hyaluronan, an injectable medication for knee arthritis, also works for arthritis at the base of the thumb. This study will also evaluate how good ultrasound is at visualizing medication in the thumb joint. We are no longer recruiting for this part of the open label trial.

Primary Outcome

The DASH Outcome Measure is a 30-item, self-report questionnaire designed to measure physical function and symptoms in people with any of several musculoskeletal disorders of the upper limb. Scores are transformed to a 0-100 scale, with a higher value indicating greater disability. The change in DASH (delta) over those 6 months was recorded.

Interventions

  • DEVICE Synvisc (hylan G-F20)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2004-10
Est. Completion 2009-12
Phase NA

What the finished NCT00198029 record still lists

NCT00198029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Synvisc (hylan G-F20) is the first listed.

NCT00198029 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00198029 about?

NCT00198029 is a clinical study titled "An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study". The purpose of this study is to find out if hyaluronan, an injectable medication for knee arthritis, also works for arthritis at the base of the thumb. This study will also evaluate how good ultrasound is at visualizing medication in the thumb joint. We are no longer recruiting for this part of the ...

What is the current status of trial NCT00198029?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2004-10. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00198029?

The interventions under investigation include: Synvisc (hylan G-F20) (DEVICE).

Who is sponsoring clinical trial NCT00198029?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00198029's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00198029, the US trial registry maintained by the National Library of Medicine. NCT00198029 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.